Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE). (2019). Reumatismo, 71(1), 24-30. https://doi.org/10.4081/reumatismo.2019.1154